What J.P. Morgan's $500M Acquisition of InstaMed Means for Philadelphia
May 20, 2019
Robert I. Field, PhD, JD, a professor in the Dornsife School of Public Health and Kline School of Law, was interviewed in an May 20 Sirius XM Knowledge@Wharton segment about whether generic drug manufacturers will pay in a recent lawsuit alleging collusion and price-fixing. Field was also quoted in a May 20 Philadelphia Business Journal article regarding J.P. Morgan's $500M acquisition of InstaMed, and what it may mean for Philadelphia.
Drexel News is produced by
University Marketing and Communications.